Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Wolfe Research analyst Andy Chen downgraded the rating for Celldex Therapeutics, Inc. (NASDAQ:CLDX) from Outperform to Peer Perform. Celldex Therapeutics shares fell 8.7% to close at $32.86 on Thursday. See how other analysts view this stock.
- Keybanc analyst Justin Patterson downgraded Bumble Inc. (NASDAQ:BMBL) from Overweight to Sector Weight. Bumble shares gained 1.9% to close at $6.44 on Thursday. See how other analysts view this stock.
- B of A Securities analyst Wamsi Mohan downgraded the rating for HP Inc. (NYSE:HPQ) from Buy to Neutral and maintained the price target of $37. HP shares gained 2.2% to close at $36.85 on Thursday. See how other analysts view this stock.
- Leerink Partners analyst Andrew Berens downgraded Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) from Outperform to Market Perform while cutting the price target from $60 to $56. Agios Pharmaceuticals shares fell 2% to close at $48.05 on Thursday. See how other analysts view this stock.
- Morgan Stanley analyst Josh Baer downgraded the rating for Udemy, Inc. (NASDAQ:UDMY) from Equal-Weight to Underweight and slashed the price target from $10 to $7.5. Udemy shares gained 1.3% to close at $8.13 on Thursday. See how other analysts view this stock.
Considering buying HP stock? Here's what analysts think:
- Top 3 Real Estate Stocks That Are Preparing To Pump This Month